Washington: The US Federal Bureau of Investigation (FDA) has issued a new warning regarding the coronavirus vaccine developed by Johnson & Johnson.
The Food and Drug Administration, the drug regulator, has updated Johnson & Johnson’s warning label for the corona vaccine, which includes information on the increased risk of developing the unique neurological disease Guillain-Barre syndrome. ۔
According to the report Johnson & Johnson is likely to develop a unique neurological condition after being vaccinated with the coronavirus, Reuters reported, adding that after reviewing a report by the Vaccine Safety Oversight Agency, authorities have confirmed that the vaccine Of the 100 people who took the dose, they were diagnosed with Galen’s syndrome.
The condition of 95 of them is critical and they needed to be hospitalized, while one death has been reported.
It is a neurological disease in which the body’s immune system damages nerve cells, which can lead to muscle weakness and, in many serious cases, paralysis. The disease affects 3,000 to 6,000 people each year in the United States. And many patients recover from it.
In a letter to the company, the FDA said that although the risk of contracting GBS after vaccination is very low, people who receive the J&J vaccine may be more likely to develop weakness, stinging, difficulty walking or facial movements. Get medical help right away if you have symptoms like difficulty.
According to the new warning label, most of the infected people showed symptoms 42 days after the dose of the vaccine and are less likely to have it, if one feels weakness or numbness of body parts especially hands and feet. She should seek medical help immediately as this condition can worsen and spread to other parts of the body.
It should be noted that not only coronary heart disease but also seasonal influenza and skin disease vaccines have been reported.